As of Oct 17
| -0.1001 / -10.01%|
The 1 analysts offering 12-month price forecasts for Rosetta Genomics Ltd have a median target of 42.00, with a high estimate of 42.00 and a low estimate of 42.00. The median estimate represents a +4,567.19% increase from the last price of 0.90.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.